PRI-101

N/A

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NamePRI-101
Drug Alias NamePRI-101
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSynuclein alpha degraders
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPriavoid
China Registration ClassN/A

Develop Information

Active CompaniesPriavoid
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A